Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Barclays Analyst Increases Price Target on ONEOK to 80

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
TMUS stock news
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Theresa Chen, a financial expert at Barclays, has reaffirmed her Equal-Weight rating on ONEOK (NYSE: OKE) and increased the price target to $80, up from $73. This adjustment reflects her optimistic view on the company’s potential growth. It is crucial to keep in mind that analysts’ opinions and price targets are fluid and can be altered due to market conditions and individual company developments.

March 7, 2024

BYON Stock Shows Strong Performance with Bullish Investor Sentiment on March 7, 2024

On March 7, 2024, BYON stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been on an upward trend over the long term.

The price of BYON shares increased by $0.50 since the market last closed, representing a 1.42% rise. The stock opened at $35.73, which was $0.61 higher than its previous close. This strong opening suggests that investors were optimistic about the company’s prospects for the day.

BYON’s price momentum and positive price change on March 7th indicate that investors are bullish on the stock. The stock’s performance suggests that there may be strong buying interest in BYON, potentially driven by positive news or developments related to the company.

BYON Stock Performance Analysis: Revenue and Net Income Decline in Q1 2024

On March 7, 2024, BYON stock experienced a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $1.56 billion for the past year, which represented a 19.08% decrease compared to the previous year. However, the total revenue remained flat at $384.46 million for the last quarter. In terms of net income, BYON reported a net loss of $307.84 million for the past year, which was a significant decrease of 773.66% compared to the previous year. However, the net loss improved slightly to $160.99 million for the last quarter, showing a 0.0% increase compared to the previous quarter. Earnings per share (EPS) for BYON also showed a decline in performance. The company reported an EPS of -$6.81 for the past year, which was a decrease of 756.43% compared to the previous year. The EPS further decreased to -$3.55 for the last quarter, representing a 154.59% decrease compared to the previous quarter. Overall, the financial performance of BYON on March 7, 2024, reflected a challenging year with declining total revenue, net income, and earnings per share. Investors may have concerns about the company’s ability to turn around its financial performance and improve profitability in the upcoming quarters. It is important for investors to closely monitor the company’s financial reports and any updates from management to make informed decisions regarding BYON stock.

Tags: BYON
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Jerry Hogge Appointed as Executive Vice President and COO of MultiPlan Corporation

Green energy

Breakthrough in Carbon Capture Technology by ESG Clean Energy Subsidiary of Camber Energy

Revolutionizing Mental Health Care Neuronetics and Transformations Care Network Forge GameChanging Partnership

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com